BILL ANALYSIS �
SCR 17
Page 1
SENATE THIRD READING
SCR 17 (La Malfa)
As Introduced February 24, 2011
Majority vote
SENATE VOTE :37-0
RULES 11-0
-----------------------------------------------------------------
|Ayes:|Skinner, Silva, Alejo, | | |
| |Butler, Carter, Mendoza, | | |
| |Donnelly, Hagman, Hueso, | | |
| |Knight, Williams | | |
| | | | |
-----------------------------------------------------------------
SUMMARY : Designates the month of September 2011 as Prostate
Cancer Awareness Month in the State of California.
Specifically, this resolution makes the following legislative
findings:
1)Prostate cancer impacts all Californians and has touched the
Senate of the State of California last year with the passing
of Senator Dave Cox after a 13-year battle with the disease.
2)In California, prostate cancer is the most common cancer among
men in all races and ethnic groups; and it is estimated that
one in six men will develop prostate cancer in their lifetime.
Approximately 20,120 men were predicted to be diagnosed with
prostate cancer in 2010; and, each day, more than eight men
will die from this disease.
3)While prostate cancer is the leading cause of cancer deaths in
men, there is little known about the disease; and, there are
no symptoms.
4)If detected and treated early, the survival rate can reach
100%, but drops to 31% when the disease spreads to other areas
of the body; which is one reason the American Cancer Society
recommends that health care providers offer men the
prostate-specific antigen (PSA) blood test and a digital
rectal examination (DRE) annually to make an early diagnosis.
5)Men who have multiple family members who have been diagnosed
SCR 17
Page 2
prior to 65 years of age and all African American men should
be offered a PSA and DRE annually beginning at 40 years of
age; and men whose father, brother, or son has been diagnosed
prior to 65 years of age should be offered a PSA and DRE
beginning at 45 years of age.
FISCAL EFFECT : None
Analysis Prepared by : Nicole Willis / RLS. / (916) 319-2800
FN: 0002511